EGFR and cancer: Furthermore, DTPs are detectable in many cancer celllines following treatment with multiple cytotoxic and targeted agents, whereasinduction of SOX2 appears to be strictly limited to targeted EGFR inhibition in cellsaddicted to mutant EGFR signaling.